Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of 
Advanced Lung Squamous Carcinoma

Clinical Observation of Recombinant Human Vascular Endostatin Durative Transfusion Combined with Window Period Arterial Infusion Chemotherapy in the Treatment of 
Advanced Lung Squamous Carcinoma

Background and objective Lung cancer is one of the most common malignant tumors in China. The aim of this study is to observe the efficacy and safety of recombinant human vascular endostatin (endostar) durative transfusion combined with window period arterial infusion chemotherapy in the treatment o...

Full description

Bibliographic Details
Main Authors: Yuan LV, Rong JIANG, Chunhua MA, Jinduo LI, Bin WANG, Liwei SUN, Ning MU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Recombinant human vascular endostatin
Arterial infusion chemotherapy
Adverse reactions
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.05

Similar Items